These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 33127881)
1. Long non-coding RNA MIAT regulates blood tumor barrier permeability by functioning as a competing endogenous RNA. He J; Xue Y; Wang Q; Zhou X; Liu L; Zhang T; Shang C; Ma J; Ma T Cell Death Dis; 2020 Oct; 11(10):936. PubMed ID: 33127881 [TBL] [Abstract][Full Text] [Related]
2. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Cai H; Xue Y; Wang P; Wang Z; Li Z; Hu Y; Li Z; Shang X; Liu Y Oncotarget; 2015 Aug; 6(23):19759-79. PubMed ID: 26078353 [TBL] [Abstract][Full Text] [Related]
3. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway. Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792 [TBL] [Abstract][Full Text] [Related]
4. KHDRBS3 regulates the permeability of blood-tumor barrier via cDENND4C/miR-577 axis. Wu P; Gao Y; Shen S; Xue Y; Liu X; Ruan X; Shao L; Liu Y; Wang P Cell Death Dis; 2019 Jul; 10(7):536. PubMed ID: 31296839 [TBL] [Abstract][Full Text] [Related]
5. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway. Zhang C; Zhang X; Wang J; Di F; Xue Y; Lin X; Zhang Y; Zhang H; Zhang Z; Gu Y FASEB J; 2020 Aug; 34(8):9941-9958. PubMed ID: 32623796 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5. Guo J; Cai H; Zheng J; Liu X; Liu Y; Ma J; Que Z; Gong W; Gao Y; Tao W; Xue Y Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2240-2254. PubMed ID: 28185956 [TBL] [Abstract][Full Text] [Related]
7. MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5. Chen L; Xue Y; Zheng J; Liu X; Liu J; Chen J; Li Z; Xi Z; Teng H; Wang P; Liu L; Liu Y Front Mol Neurosci; 2018; 11():35. PubMed ID: 29467620 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140. Ma J; Wang P; Yao Y; Liu Y; Li Z; Liu X; Li Z; Zhao X; Xi Z; Teng H; Liu J; Xue Y Biochim Biophys Acta; 2016 Feb; 1859(2):324-38. PubMed ID: 26619802 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of piR-DQ590027/MIR17HG regulating the permeability of glioma conditioned normal BBB. Leng X; Ma J; Liu Y; Shen S; Yu H; Zheng J; Liu X; Liu L; Chen J; Zhao L; Ruan X; Xue Y J Exp Clin Cancer Res; 2018 Oct; 37(1):246. PubMed ID: 30305135 [TBL] [Abstract][Full Text] [Related]
10. Biosynthetic CircRNA_001160 induced by PTBP1 regulates the permeability of BTB via the CircRNA_001160/miR-195-5p/ETV1 axis. Li H; Shen S; Ruan X; Liu X; Zheng J; Liu Y; Yang C; Wang D; Liu L; Ma J; Ma T; Wang P; Cai H; Li Z; Zhao L; Xue Y Cell Death Dis; 2019 Dec; 10(12):960. PubMed ID: 31862871 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA USP1 regulates the permeability of blood-tumour barrier via miR-194-5p/FLI1 axis. Gao Y; Wu P; Ma Y; Xue Y; Liu Y; Zheng J; Liu X; He Q; Ma J; Liu L; Wang P J Cell Mol Med; 2020 Jan; 24(1):342-355. PubMed ID: 31654502 [TBL] [Abstract][Full Text] [Related]
12. The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier. Liu J; Liu L; Chao S; Liu Y; Liu X; Zheng J; Chen J; Gong W; Teng H; Li Z; Wang P; Xue Y Front Cell Neurosci; 2017; 11():358. PubMed ID: 29311822 [TBL] [Abstract][Full Text] [Related]
13. MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p/miR-382-5p mediated ZIC4 expression change. He Q; Zhao L; Liu X; Zheng J; Liu Y; Liu L; Ma J; Cai H; Li Z; Xue Y J Exp Clin Cancer Res; 2019 Jan; 38(1):9. PubMed ID: 30621721 [TBL] [Abstract][Full Text] [Related]
14. MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5. Miao YS; Zhao YY; Zhao LN; Wang P; Liu YH; Ma J; Xue YX Cell Signal; 2015 Jan; 27(1):156-67. PubMed ID: 25452107 [TBL] [Abstract][Full Text] [Related]
15. The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB. Sa L; Li Y; Zhao L; Liu Y; Wang P; Liu L; Li Z; Ma J; Cai H; Xue Y Front Mol Neurosci; 2017; 10():194. PubMed ID: 28701916 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin. Zhao YY; Zhao LN; Wang P; Miao YS; Liu YH; Wang ZH; Ma J; Li Z; Li ZQ; Xue YX J Neurosci Res; 2015 Dec; 93(12):1891-902. PubMed ID: 26356851 [TBL] [Abstract][Full Text] [Related]
17. MiR-181a regulates blood-tumor barrier permeability by targeting Krüppel-like factor 6. Ma J; Yao Y; Wang P; Liu Y; Zhao L; Li Z; Li Z; Xue Y J Cereb Blood Flow Metab; 2014 Nov; 34(11):1826-36. PubMed ID: 25182666 [TBL] [Abstract][Full Text] [Related]
18. MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cε. Zhao W; Wang P; Ma J; Liu YH; Li Z; Li ZQ; Wang ZH; Chen LY; Xue YX Mol Biol Cell; 2015 May; 26(10):1786-96. PubMed ID: 25788289 [TBL] [Abstract][Full Text] [Related]
19. SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway. Liu X; Shen S; Zhu L; Su R; Zheng J; Ruan X; Shao L; Wang D; Yang C; Liu Y J Exp Clin Cancer Res; 2020 Jun; 39(1):121. PubMed ID: 32600379 [TBL] [Abstract][Full Text] [Related]
20. FXR1 stabilizes SNORD63 to regulate blood-tumor barrier permeability through SNORD63 mediated 2'-O-methylation of POU6F1. Liang C; Zhai B; Wei D; Niu B; Ma J; Yao Y; Lin Y; Liu Y; Liu X; Wang P Int J Biol Macromol; 2024 Apr; 265(Pt 1):130642. PubMed ID: 38460644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]